Qualcomm, Tesla Surge as Intellia Plummets After Clinical Trial Pause; Avidity Bought for $12B
Qualcomm and Tesla surged on AI chips and strong earnings, while Intellia Therapeutics plunged 45% after pausing gene therapy trials. Avidity Biosciences jumped 42% after Novartis agreed to buy it for $12 billion amid cooling U.S.-China trade tensions.
